Answers are grounded in this paper and cite their sources.
Demonstrates effectiveness of enhanced organic upconversion devices for bioimaging and information security.
Organic upconversion devices (OUPCs) that convert near-infrared (NIR) photons into visible emission offer a promising platform for NIR visualization and detection, yet their practical deployment is hindered by high turn-on voltages and strong sensitivity to emitter composition. Here, we report a three-channel exciplex emitter architecture that enables low-voltage, emitter compositional-tolerant OUPCs. Benefiting from synergistic multichannel energy transfer and efficient reverse intersystem crossing within the exciplex system, the light-emitting unit exhibits a low turn-on voltage of 2.3 V and a maximum external quantum efficiency of 18%. Notably, nearly invariant emission performance is maintained over a wide D:A ratio range (DBT-SADF:PO-T2T from 2:8 to 8:2), with coefficients of variation of 0.11 for external quantum efficiency, indicating good processing tolerance. Based on this emitter, the resulting OUPC achieves an ultralow upconversion turn-on voltage of 1.6 V under 850 nm excitation, a maximum luminance on:off ratio exceeding 3.1 × 10 6, a detectivity of more than 1.5 × 10 13 Jones, and visible emission (3 cd/m 2 ) even at a weak NIR power density of 7 μW/cm 2 . Benefiting from the high-performance OUPC, we successfully achieved encrypted image decryption and bioimaging. These findings demonstrate that the proposed exciplex emitter strategy not only eliminates the reliance on heavy-metal emitters but also simultaneously enhances device performance and application potential, providing a scalable approach for NIR information visualization.
No takes yet. Share an insight, caveat, or question.
Lei et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: